Generic Cases Still Face Tough Odds After High Court Snub
The U.S. Supreme Court recently refused to reconsider the Iowa Supreme Court ruling in Pliva v. Huck, which had allowed generic-drug makers to face failure-to-update labeling claims, but experts say that...To view the full article, register now.
Already a subscriber? Click here to view full article